Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

This treatment has been approved for sale to the public.
Sponsor:
Collaborator:
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):
BTG International Inc.
ClinicalTrials.gov Identifier:
NCT00481559
First received: May 30, 2007
Last updated: January 16, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This treatment has been approved for sale to the public.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given